Clinical Trials Arena on MSN
Agomab’s ALK5 inhibitor to advance to Phase IIb in Crohn’s disease
Ontunisertib could become the first FDA-approved anti-fibrotic suitable for Crohn’s disease patients with symptomatic ...
ScienceAlert on MSN
A Crucial Genetic Mutation Behind Crohn's Disease Has Finally Been Revealed
Mutations in a gene associated with Crohn's disease have been found to rob critical immune cells of their ability to switch ...
Proactive care and early treatment help prevent serious IBD complications and improve patients’ quality of life.
A family says their car was totaled in a hit-and-run, and police said the person who struck them was a high-ranking member of ...
Following the NDA submission for icotrokinra treatment of adults and adolescents with moderate to severe plaque psoriasis to the U.S. FDA in July, the European Medicines Agency (EMA) application was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results